1. Catalog
  2. How long is long-acting? Understanding new guidanc ...
How long is long-acting? Understanding new guidance on extended use of LARC
Clinical practice Contraception
This previously recorded webinar was held on October 27, 2022 and covered the efficacy of LARC devices beyond the FDA-approved window, special considerations with extended LARC use, and centering patient preference.
Availability
No future session
Cost
$0.00
Credit Offered
1 CME Credit


Physicians: The Society of Family Planning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Society of Family Planning designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: For the purpose of recertification, the American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.

Physician Assistants: Physician Assistants may claim a maximum of 1.0 Category 1 credits for completing this activity. The National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Other Healthcare Professionals: All non-physician healthcare professionals who complete this accredited activity will receive a certificate documenting completion of the course and associated credit. Many societies and credentialing bodies accept accredited CME activities as long as the topic is relevant to the applicant’s field or discipline.

If you have questions whether this activity meets the education or licensure requirements for your discipline, please consult your licensing or certifying board. You may also contact our Continuing Education team at CME@SocietyFP.org for support.

At the conclusion of this activity, participants will be able to:  
1. Understand the evidence regarding the efficacy of LARC devices beyond the FDA-approved window.
2. Recognize any special considerations regarding extended LARC use, such as BMI above 30, age, bleeding patterns, medication interactions, and device removal.
3. Center patient preference in counseling individuals regarding extended use of LARC.
pdf document link
Powered By